These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 7531775)
1. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. Richardson RJ J Toxicol Environ Health; 1995 Feb; 44(2):135-65. PubMed ID: 7531775 [TBL] [Abstract][Full Text] [Related]
2. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. Kropp TJ; Richardson RJ J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk. Richardson RJ; Moore TB; Kayyali US; Fowke JH; Randall JC Fundam Appl Toxicol; 1993 Apr; 20(3):273-9. PubMed ID: 7684990 [TBL] [Abstract][Full Text] [Related]
4. Chlorpyrifos: assessment of potential for delayed neurotoxicity by repeated dosing in adult hens with monitoring of brain acetylcholinesterase, brain and lymphocyte neurotoxic esterase, and plasma butyrylcholinesterase activities. Richardson RJ; Moore TB; Kayyali US; Randall JC Fundam Appl Toxicol; 1993 Jul; 21(1):89-96. PubMed ID: 7689993 [TBL] [Abstract][Full Text] [Related]
6. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro. Jianmongkol S; Berkman CE; Thompson CM; Richardson RJ Toxicol Appl Pharmacol; 1996 Aug; 139(2):342-8. PubMed ID: 8806851 [TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. Malygin VV; Sokolov VB; Richardson RJ; Makhaeva GF J Toxicol Environ Health A; 2003 Apr; 66(7):611-25. PubMed ID: 12746136 [TBL] [Abstract][Full Text] [Related]
8. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome. Karanth S; Olivier K; Liu J; Pope C Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124 [TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase and neuropathy target esterase in chickens treated with acephate. Wilson BW; Henderson JD; Kellner TP; McEuen SF; Griffis LC; Lai JC Neurotoxicology; 1990; 11(3):483-91. PubMed ID: 2284053 [TBL] [Abstract][Full Text] [Related]
10. Determination of the reference dose for chlorpyrifos: proceedings of an expert panel. Clegg DJ; van Gemert M J Toxicol Environ Health B Crit Rev; 1999; 2(3):211-55. PubMed ID: 10429680 [TBL] [Abstract][Full Text] [Related]
11. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. Huff RA; Corcoran JJ; Anderson JK; Abou-Donia MB J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: toxicological implications. Quistad GB; Sparks SE; Segall Y; Nomura DK; Casida JE Toxicol Appl Pharmacol; 2002 Feb; 179(1):57-63. PubMed ID: 11884237 [TBL] [Abstract][Full Text] [Related]
13. The developmental neurotoxicity of organophosphorus insecticides: a direct role for the oxon metabolites. Flaskos J Toxicol Lett; 2012 Feb; 209(1):86-93. PubMed ID: 22155227 [TBL] [Abstract][Full Text] [Related]
14. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Ehrich M; Correll L; Veronesi B Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605 [TBL] [Abstract][Full Text] [Related]
16. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. Clegg DJ; van Gemert M J Toxicol Environ Health B Crit Rev; 1999; 2(3):257-79. PubMed ID: 10429681 [TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon. Carr RL; Chambers JE Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854 [TBL] [Abstract][Full Text] [Related]
18. Concentration-dependent binding of chlorpyrifos oxon to acetylcholinesterase. Sultatos LG Toxicol Sci; 2007 Nov; 100(1):128-35. PubMed ID: 17702992 [TBL] [Abstract][Full Text] [Related]
19. QSAR for the organophosphate-induced inhibition and 'aging' of the enzyme neuropathy target esterase (NTE). Singh AK SAR QSAR Environ Res; 2001; 12(3):275-95. PubMed ID: 11696925 [TBL] [Abstract][Full Text] [Related]